PKD1 and rheumatoid arthritis: Considering the role of PKD1 in TLR/IL-1R signal transduction and proinflammatory responses, and contributions of TLR/IL-1R on experimental inflammatory arthritis and human RA, a pharmacological agent that can inhibit function of PKD1 might be a reasonable new candidate as a disease-modifying drug for RA.